CN Patent

CN111150729B — 一种成膜组合物及其应用

Assigned to Individual · Expires 2021-02-12 · 5y expired

What this patent protects

本发明涉及一种成膜组合物及其应用，具体地，所述成膜组合物包含大麻二酚和褪黑素以及乳化剂、成膜剂、增重剂、消泡剂等辅料。由本发明的成膜组合物制得的膜可速溶于水且不黏腻、耐牵拉，在制膜过程中不易起皱、不易断裂，产品质量高且产量高。

USPTO Abstract

本发明涉及一种成膜组合物及其应用，具体地，所述成膜组合物包含大麻二酚和褪黑素以及乳化剂、成膜剂、增重剂、消泡剂等辅料。由本发明的成膜组合物制得的膜可速溶于水且不黏腻、耐牵拉，在制膜过程中不易起皱、不易断裂，产品质量高且产量高。

Drugs covered by this patent

Abilify (aripiprazole) · Generic (originally Otsuka/BMS)

Patent Metadata

Patent number: CN111150729B
Jurisdiction: CN
Classification: —
Expires: 2021-02-12
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.